Cara Therapeutics, Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (3)
- Stock Agreements (2)
- Underwriting Agreements (5)
- Warrant Agreements (1)
- Asset Purchase Agreement, dated December 17, 2024, by and among Cara Therapeutics, Inc. Cara Royalty Sub, LLC and Vifor Fresenius Medical Care Renal Pharma, Ltd (Filed With SEC on December 18, 2024)
- Purchase and Sale Agreement dated November 1, 2023 by and between Cara Royalty Sub, LLC and HCRX Investments Holdco, L.P. and Healthcare Royalty Partners IV, L.P (Filed With SEC on March 6, 2024)
- Securities Purchase Agreement, dated October 15, 2020, by and between the Registrant and Vifor (International) Ltd (Filed With SEC on February 25, 2021)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under Cara Therapeutics, Inc. 2019 Inducement Plan (Filed With SEC on November 20, 2019)
- Form of Stock Option Grant Notice and Stock Option Agreement under Cara Therapeutics, Inc. 2019 Inducement Plan (Filed With SEC on November 20, 2019)
- Underwriting Agreement, dated July 24, 2019 (Filed With SEC on July 29, 2019)
- Underwriting Agreement dated July 18, 2018 (Filed With SEC on July 23, 2018)
- 4,450,000 Shares CARATHERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 3, 2017)
- 3,763,440 Shares CARATHERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 31, 2015)
- Shares CARA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 17, 2014)
- CARA THERAPEUTICS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on November 8, 2013)
- STOCK SUBSCRIPTION WARRANT To Purchase 49,628 Shares of Common Stock of CARA THERAPEUTICS, INC. (the Company) DATE OF INITIAL ISSUANCE: September 25, 2007 (Filed With SEC on November 8, 2013)
